Max Jan
About Max Jan
Max Jan is a Molecular Pathologist with a focus on innovation in molecular diagnostics for cancer patients. He currently holds positions at the Broad Institute of MIT and Harvard, Harvard Medical School, and Massachusetts General Hospital.
Work at Broad Institute
Max Jan has been employed at the Broad Institute of MIT and Harvard since 2021, serving as a Molecular Pathologist. In this role, he contributes to research and development in the field of molecular diagnostics, particularly focusing on cancer. His work involves leveraging advanced techniques to enhance diagnostic capabilities for cancer patients.
Education and Expertise
Max Jan holds an MD from the University of California, San Francisco - School of Medicine, where he studied from 2011 to 2015. He also earned a PhD in Cancer Biology from Stanford University School of Medicine, studying from 2007 to 2011. Additionally, he has a BA in Molecular Biology from Princeton University, completed between 2003 and 2007. His educational background equips him with a strong foundation in both medicine and molecular biology.
Background
Max Jan's professional journey includes significant roles in prestigious institutions. Prior to his current positions, he was a Molecular Genetic Pathology Fellow at Harvard Medical School from 2018 to 2021 and a Resident Physician at Massachusetts General Hospital from 2015 to 2018. His experience spans various aspects of pathology and molecular diagnostics, contributing to his expertise in the field.
Achievements in Cancer Research
Max Jan has developed a synthetic biology toolkit designed for cell therapy applications, focusing on targeted protein degradation. His research emphasizes innovation in molecular diagnostics, specifically aimed at improving outcomes for cancer patients. He is actively involved in projects at the Center for Cancer Research and the Department of Pathology in Boston, Massachusetts.
Current Role at Harvard Medical School
Since 2021, Max Jan has held the position of Assistant Professor of Pathology at Harvard Medical School. In this capacity, he engages in teaching and research, furthering the understanding of molecular pathology and its applications in cancer diagnosis and treatment.